ALK and anaplastic large cell lymphoma: Further, Petrazzuolo et al. found that crizotinib and ceritinib induced anaplastic lymphoma kinase (ALK)-dependent ICD in anaplastic large cell lymphoma (Petrazzuolo et al., 2021).